Skip to main content

Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation

Annals of Hematology volume 92, pages 111–119 (2013)Cite this article

Abstract

Beside many risk factors in patients considered for alloHCT, only body mass index (BMI) as a broad marker of nutritional status has prognostic value in these patients. This is the first prospective study to investigate the validity of further nutritional markers: adjusted BMI, normalized for gender and age; Subjective Global Assessment questionnaire and standardized phase angle, normalized for gender, age and BMI in 105 patients as independent risk factors for outcomes [overall survival (OS), non-relapse mortality (NRM), relapse mortality (RM), progression-free survival (PFS)] until 2 years after alloHCT. In Cox proportional-hazards regression models, we included a variety of accepted risk factors. The two most influential pre-transplant risk factors identified and associated with similarly increased hazard ratios (HR) for OS, RM, and PFS were a low-standardized phase angle (HR = 1.97, P = 0.043; HR = 3.18, P = 0.017, and HR = 1.91, P = 0.039) and advanced disease. Under- and overweight according BMI percentiles (≤10th; ≥90th) revealed associations with increased risk of NRM (HR = 2.90, P = 0.018; HR = 3.02, P = 0.062), although only low BMI was weakly associated with OS (HR = 1.82, P = 0.09). In conclusion, our results demonstrate that pre-transplant phase angle is an independent predictor for 2-year outcomes in these patients. Further investigation is necessary to demonstrate whether the theoretically modifiable phase angle can be increased by physical training combined with nutritional support, and if this improves outcome after alloHCT.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Bearman SI, Appelbaum FR, Back A, Petersen FB, Buckner CD, Sullivan KM, Schoch HG, Fisher LD, Thomas ED (1989) Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. J Clin Oncol 7(9):1288–1294

    PubMed  CAS  Google Scholar 

  2. Bertz H, Illerhaus G, Veelken H, Finke J (2002) Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens. Ann Oncol 13(1):135–139

    PubMed  Article  CAS  Google Scholar 

  3. Bevans MF, Mitchell SA, Marden S (2008) The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer 16(11):1243–1254

    PubMed  Article  Google Scholar 

  4. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C (1998) Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338(14):962–968

    PubMed  Article  CAS  Google Scholar 

  5. Le Blanc K, Ringden O, Remberger M (2003) A low body mass index is correlated with poor survival after allogeneic stem cell transplantation. Haematologica 88(9):1044–1052

    PubMed  Google Scholar 

  6. Lenssen P, Sherry ME, Cheney CL, Nims JW, Sullivan KM, Stern JM, Moe G, Aker SN (1990) Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc 90(6):835–842

    PubMed  CAS  Google Scholar 

  7. Nikolousis E, Nagra S, Paneesha S, Delgado J, Holder K, Bratby L, Chaganti S, Lovell R, Milligan D (2010) Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies. Ann Hematol 89(11):1141–1145

    PubMed  Article  Google Scholar 

  8. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106(8):2912–2919

    PubMed  Article  CAS  Google Scholar 

  9. Correia MI, Waitzberg DL (2003) The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr 22(3):235–239

    PubMed  Article  Google Scholar 

  10. Gupta D, Lis CG, Dahlk SL, Vashi PG, Grutsch JF, Lammersfeld CA (2004) Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr 92(6):957–962

    PubMed  Article  CAS  Google Scholar 

  11. Horsley P, Bauer J, Gallagher B (2005) Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transpl 35(11):1113–1116

    Article  CAS  Google Scholar 

  12. Isenring E, Cross G, Daniels L, Kellett E, Koczwara B (2006) Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer 14(11):1152–1156

    PubMed  Article  Google Scholar 

  13. Barbosa-Silva MC, Barros AJ (2005) Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care 8(3):311–317

    PubMed  Article  Google Scholar 

  14. Norman K, Stobaus N, Zocher D, Bosy-Westphal A, Szramek A, Scheufele R, Smoliner C, Pirlich M (2010) Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr 92(3):612–619

    PubMed  Article  CAS  Google Scholar 

  15. Faisy C, Rabbat A, Kouchakji B, Laaban JP (2000) Bioelectrical impedance analysis in estimating nutritional status and outcome of patients with chronic obstructive pulmonary disease and acute respiratory failure. Intensive Care Med 26(5):518–525

    PubMed  Article  CAS  Google Scholar 

  16. Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, Hoffman S, Lis CG (2004) Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 80(6):1634–1638

    PubMed  CAS  Google Scholar 

  17. Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis CG (2008) Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 8:249

    PubMed  Article  Google Scholar 

  18. Toso S, Piccoli A, Gusella M, Menon D, Bononi A, Crepaldi G, Ferrazzi E (2000) Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition 16(2):120–124

    PubMed  Article  CAS  Google Scholar 

  19. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN (1987) What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 11(1):8–13

    PubMed  Article  CAS  Google Scholar 

  20. Detsky AS, Baker JP, Mendelson RA, Wolman SL, Wesson DE, Jeejeebhoy KN (1984) Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J Parenter Enteral Nutr 8(2):153–159

    PubMed  Article  CAS  Google Scholar 

  21. Read JA, Choy ST, Beale PJ, Clarke SJ (2006) Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 55(1):78–85

    PubMed  Article  CAS  Google Scholar 

  22. Hemmelmann C, Brose S, Vens M, Hebebrand J, Ziegler A (2010) [Percentiles of body mass index of 18-80-year-old German adults based on data from the Second National Nutrition Survey]. Dtsch Med Wochenschr 135(17):848–852

    PubMed  Article  CAS  Google Scholar 

  23. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AM, Pichard C (2004) Bioelectrical impedance analysis–part I: review of principles and methods. Clin Nutr 23(5):1226–1243

    PubMed  Article  Google Scholar 

  24. Baumgartner RN, Chumlea WC, Roche AF (1988) Bioelectric impedance phase angle and body composition. Am J Clin Nutr 48(1):16–23

    PubMed  CAS  Google Scholar 

  25. Fredrix EW, Saris WH, Soeters PB, Wouters EF, Kester AD, von Meyenfeldt MF, Westerterp KR (1990) Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr 44(10):749–752

    PubMed  CAS  Google Scholar 

  26. Paiva SI, Borges LR, Halpern-Silveira D, Assuncao MC, Barros AJ, Gonzalez MC (2011) Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer. Support Care Cancer 19(2):187–192

    Article  Google Scholar 

  27. Schwenk A, Beisenherz A, Romer K, Kremer G, Salzberger B, Elia M (2000) Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr 72(2):496–501

    PubMed  CAS  Google Scholar 

  28. Bosy-Westphal A, Danielzik S, Dorhofer RP, Later W, Wiese S, Muller MJ (2006) Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. JPEN J Parenter Enteral Nutr 30(4):309–316

    PubMed  Article  Google Scholar 

  29. Barbosa-Silva MC, Barros AJ, Wang J, Heymsfield SB, Pierson RN Jr (2005) Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr 82(1):49–52

    PubMed  CAS  Google Scholar 

  30. Kushner RF, Schoeller DA (1986) Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr 44(3):417–424

    PubMed  CAS  Google Scholar 

  31. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI (1985) Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41(4):810–817

    PubMed  CAS  Google Scholar 

  32. Segal KR, Gutin B, Presta E, Wang J, Van Itallie TB (1985) Estimation of human body composition by electrical impedance methods: a comparative study. J Appl Physiol 58(5):1565–1571

    PubMed  CAS  Google Scholar 

  33. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gomez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AMWJ, Pichard C (2004) Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 23(6):1430–1453

    PubMed  Article  Google Scholar 

  34. Marks R, Potthoff K, Hahn J, Ihorst G, Bertz H, Spyridonidis A, Holler E, Finke JM (2008) Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies. Blood 112(2):415–425

    PubMed  Article  CAS  Google Scholar 

  35. Dittmar M (2003) Reliability and variability of bioimpedance measures in normal adults: effects of age, gender, and body mass. Am J Phys Anthropol 122(4):361–370

    PubMed  Article  Google Scholar 

  36. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799

    PubMed  Article  CAS  Google Scholar 

  37. Johansen KL, Kaysen GA, Young BS, Hung AM, da Silva M, Chertow GM (2003) Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr 77(4):842–846

    PubMed  CAS  Google Scholar 

  38. Biolo G, Tipton KD, Klein S, Wolfe RR (1997) An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am J Physiol 273(1 Pt 1):E122–E129

    PubMed  CAS  Google Scholar 

  39. Esmarck B, Andersen JL, Olsen S, Richter EA, Mizuno M, Kjaer M (2001) Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans. J Physiol 535(Pt 1):301–311

    PubMed  Article  CAS  Google Scholar 

  40. Levenhagen DK, Carr C, Carlson MG, Maron DJ, Borel MJ, Flakoll PJ (2002) Postexercise protein intake enhances whole-body and leg protein accretion in humans. Med Sci Sports Exerc 34(5):828–837

    PubMed  Article  CAS  Google Scholar 

  41. Wiskemann J, Huber G (2008) Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transpl 41(4):321–329

    Article  CAS  Google Scholar 

  42. Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N, Ulrich CM, Bohus M (2011) Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood 117(9):2604–2613

    PubMed  Article  CAS  Google Scholar 

  43. Baumann FT, Zopf EM, Nykamp E, Kraut L, Schule K, Elter T, Fauser AA, Bloch W (2011) Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 87(2):148–156

    PubMed  Article  Google Scholar 

  44. Dickson TM, Kusnierz-Glaz CR, Blume KG, Negrin RS, Hu WW, Shizuru JA, Johnston LL, Wong RM, Stockerl-Goldstein KE (1999) Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biol Blood Marrow Transpl 5(5):299–305

    Article  CAS  Google Scholar 

  45. Navarro WH, Loberiza FR Jr, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, Rizzo JD (2006) Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transpl 12(5):541–551

    Article  Google Scholar 

  46. Deeg HJ, Seidel K, Bruemmer B, Pepe MS, Appelbaum FR (1995) Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transpl 15(3):461–468

    CAS  Google Scholar 

  47. Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD (2010) Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transpl 16(10):1442–1450

    Article  Google Scholar 

  48. Hadjibabaie M, Iravani M, Taghizadeh M, Ataie-Jafari A, Shamshiri AR, Mousavi SA, Alimoghaddam K, Hosseini S, Ghavamzadeh A (2008) Evaluation of nutritional status in patients undergoing hematopoietic SCT. Bone Marrow Transpl 42(7):469–473

    Article  CAS  Google Scholar 

  49. Fleming DR, Rayens MK, Garrison J (1997) Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study. Am J Med 102(3):265–268

    PubMed  Article  CAS  Google Scholar 

  50. Blouin RA, Warren GW (1999) Pharmacokinetic considerations in obesity. J Pharm Sci 88(1):1–7

    PubMed  Article  CAS  Google Scholar 

  51. Hanley MJ, Abernethy DR, Greenblatt DJ (2010) Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 49(2):71–87

    PubMed  Article  CAS  Google Scholar 

  52. Jain R, Chung SM, Jain L, Khurana M, Lau SW, Lee JE, Vaidyanathan J, Zadezensky I, Choe S, Sahajwalla CG (2011) Implications of obesity for drug therapy: limitations and challenges. Clin Pharmacol Ther 90(1):77–89

    PubMed  Article  CAS  Google Scholar 

  53. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999) The disease burden associated with overweight and obesity. JAMA 282(16):1523–1529

    PubMed  Article  CAS  Google Scholar 

  54. Caraco Y, Zylber-Katz E, Berry EM, Levy M (1995) Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism. Eur J Clin Pharmacol 47(6):525–530

    PubMed  Article  CAS  Google Scholar 

  55. Hingorani P, Seidel K, Krailo M, Mascarenhas L, Meyers P, Marina N, Conrad EU, Hawkins DS (2011) Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 57(6):939–942

    PubMed  Article  Google Scholar 

  56. Scrimshaw NS, SanGiovanni JP (1997) Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 66(2):464S–477S

    PubMed  CAS  Google Scholar 

  57. Bozzetti F, Gianotti L, Braga M, Di Carlo V, Mariani L (2007) Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr 26(6):698–709

    PubMed  Article  Google Scholar 

  58. Paiva SI, Borges LR, Halpern-Silveira D, Assunção MC, Barros AJ, Gonzalez MC (2010) Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer. Support Care Cancer 19(2):187–192

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

We are grateful to Carole Cuerten for proofreading this manuscript. P. Urbain was supported by a PhD grant from the National Research Fund, Luxemburg.

Conflict of interst

The authors declare no conflict of interest.

Author information

Affiliations

  1. Department of Haematology/Oncology, Section of Nutrition, Albert Ludwigs-University Medical Center Freiburg, Freiburg, Germany

    Paul Urbain & Jakob Birlinger

  2. Institute of Medical Biometry and Medical Informatics, Albert Ludwigs-University Medical Center Freiburg, Freiburg, Germany

    Gabriele Ihorst

  3. Department of Biological Chemistry and Nutrition, University of Hohenheim, Stuttgart, Germany

    Paul Urbain & Hans-Konrad Biesalski

  4. Department of Haematology/Oncology, Section of Allogeneic Stem Cell Transplantation, Albert Ludwigs-University Medical Center Freiburg, Freiburg, Germany

    Juergen Finke & Hartmut Bertz

  5. Department of Hematology/Oncology, Section of Nutrition, University Medical Center, Hugstetter Str 55, 79106, Freiburg, Germany

    Paul Urbain

Authors
  1. Paul Urbain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jakob Birlinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gabriele Ihorst
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hans-Konrad Biesalski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juergen Finke
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hartmut Bertz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Urbain.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Urbain, P., Birlinger, J., Ihorst, G. et al. Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation. Ann Hematol 92, 111–119 (2013). https://doi.org/10.1007/s00277-012-1573-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1573-4

Keywords

  • Nutritional status
  • BMI
  • Phase angle
  • Outcome
  • Allogeneic hematopoietic cell transplantation
  • BMT